Heparin and Lignocaine recall, isolated incident likely

recall regulatory
The TGA and Pfizer are working on a recall for Heparin and Lignocaine ampoules following a reported product mix-up The TGA said in a statement on Monday (14 August) that it is working with Pfizer Australia on the recall notice for the two medicines, following one instance of a product mix-up. The affected medicines are

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous PSA appointment for Bob Buckham
Next Pharmacists in general practice get 100%